Claudin-15 is a member of the claudin family, integral membrane proteins that form the backbone of tight junctions. These junctions regulate paracellular permeability, maintain cell polarity, and participate in immune cell transmigration . Recombinant CLDN15 is produced via heterologous expression systems to mimic its native structure and function, enabling precise experimental control over its expression levels and localization .
Recombinant CLDN15 is employed in diverse research contexts:
In Schwann cell models, overexpression of CLDN15 via plasmid transfection (pGV230-Claudin-15) demonstrated:
Inhibited Proliferation: Reduced EdU incorporation compared to controls .
Promoted Apoptosis: Increased apoptotic rates (flow cytometry) and elevated Bax expression .
Modulated Neurotrophins: Upregulated basic fibroblast growth factor (bFGF) and neurotrophin-3 (NT3) .
Antibodies like Mouse Anti-Human Claudin-15 Monoclonal Antibody (MAB10344) enable precise detection via:
Flow Cytometry: Validated in HEK293 cells transfected with CLDN15 .
Immunohistochemistry (IHC): Used to assess tissue-specific expression .
While CLDN15 itself is not yet a clinical target, insights from related claudins (e.g., CLDN6, CLDN18.2) highlight potential therapeutic pathways:
Antibody-Drug Conjugates (ADCs): CLDN18.2-targeted ADCs showed efficacy in pancreatic and gastric cancer xenografts .
CAR-T Cell Therapy: CLDN6-targeted CAR-T cells achieved partial responses in refractory solid tumors .
CLDN15’s role in Schwann cell apoptosis suggests potential applications in nerve regeneration studies, though no clinical trials are currently documented .
| Parameter | CLDN15 Overexpression | CLDN15 Knockdown |
|---|---|---|
| Proliferation | ↓ (EdU assay) | ↑ (EdU assay) |
| Apoptosis | ↑ (Flow cytometry) | ↓ (Flow cytometry) |
| bFGF/NT3 Expression | ↑ | ↑ |